Back
Energy Fuels 10K Form
Buy
62
EFR.TO
Energy Fuels
Last Price:
9.07
Seasonality Move:
41.61%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2021-03-22 | 10K | EFR.TO/Energy Fuels Annual |
2020-11-02 | 10Q | EFR.TO/Energy Fuels Quarterly |
2020-08-03 | 10Q | EFR.TO/Energy Fuels Quarterly |
2020-05-04 | 10Q | EFR.TO/Energy Fuels Quarterly |
2020-03-17 | 10K | EFR.TO/Energy Fuels Annual |
2019-11-04 | 10Q | EFR.TO/Energy Fuels Quarterly |
Receive EFR.TO News And Ratings
See the #1 stock for the next 7 days that we like better than EFR.TO
EFR.TO Financial Statistics
Sales & Book Value
Annual Sales: | $51.2M |
---|---|
Cash Flow: | $-19.9M |
Price / Cash Flow: | 0 |
Annual Sales: | $3.06 |
Price / Book: | 3.55 |
Profitability
EPS (TTM): | -0.30020 |
---|---|
Net Income (TTM): | $-47.7M |
Gross Margin: | $26.65M |
Return on Equity: | -9.24% |
Return on Assets: | -8.77% |
Energy Fuels Earnings Forecast
Key Energy Fuels Financial Ratios
- The Gross Profit Margin over the past 15 years for EFR.TO is 52.06%.
- The Selling, General & Administrative Expenses for EFR.TO have been equal to 73.60% of Gross Profit Margin.
- The Research & Development expenses have been 31.26% of Revenue.
- The Interest Expense is -0.28% of Operating Income.
- The Net Earning history of EFR.TO is 263.29% of Total Revenues.
- Per Share Earnings over the last 24 years have been positive in 17 years.
Energy Fuels Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | TSX |
---|---|
Industry: | Oil, Gas & Consumable Fuels |
Sector: | Energy |
Current Symbol: | EFR.TO |
Website: | energyfuels.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 18.01 |
Quick Ratio: | 14.26 |
Price-to-Earnings
Trailing P/E Ratio: | 10.85 |
---|---|
Forward P/E Ratio: | 0 |
EFR.TO Technical Analysis vs Fundamental Analysis
Buy
62
Energy Fuels (EFR.TO)
is a Buy
Is Energy Fuels a Buy or a Sell?
-
Energy Fuels stock is rated a Buy
The current Energy Fuels [EFR.TO] share price is $9.08. The Score for EFR.TO is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.